0001209191-20-036497.txt : 20200615
0001209191-20-036497.hdr.sgml : 20200615
20200615073346
ACCESSION NUMBER: 0001209191-20-036497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200611
FILED AS OF DATE: 20200615
DATE AS OF CHANGE: 20200615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Halfon Jean Michel
CENTRAL INDEX KEY: 0001721516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 20961912
MAIL ADDRESS:
STREET 1: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-11
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001721516
Halfon Jean Michel
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
1
0
0
0
Ordinary Shares
2020-06-11
4
M
0
17621
A
22563
D
Restricted Share Units
2020-06-11
4
M
0
17621
0.00
D
Ordinary Shares
17621
0
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on June 11, 2019 and vested on June 11, 2020.
/s/ Dov Bergwerk as attorney-in-fact for Jean-Michel Halfon
2020-06-15